This HTML5 document contains 110 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q54086129
rdf:type
wikibase:Item
schema:description
bilimsel makale 1992年学术文章 mokslinis straipsnis مقالة علمية מאמר מדעי artículo científico publicado en 1992 scientific article article científic научная статья vedecký článok tudományos cikk videnskabelig artikel (udgivet 1992) 1992년 논문 teaduslik artikkel ১৯৯২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ мақолаи илмӣ 1992年學術文章 мақолаи илмӣ 1992年學術文章 articolo scientifico artigo científico (publicado na 1992) 1992年学术文章 article scientifique (publié 1992) vědecký článek บทความทางวิทยาศาสตร์ 1992年学术文章 artikulong pang-agham научни чланак научни чланак vitenskapelig artikkel научна статия 1992年學術文章 1992年學術文章 artykuł naukowy 1992年学术文章 наукова стаття, опублікована в січні 1992 scienca artikolo artículu científicu artigo científico (publicado na 1992) vitskapeleg artikkel artikull shkencor επιστημονικό άρθρο 1992 nî lūn-bûn wetenschappelijk artikel tieteellinen artikkeli wissenschaftlicher Artikel artigo científico articol științific vetenskaplig artikel naučni članak 1992年學術文章 1992年學術文章 article scientific სამეცნიერო სტატია գիտական հոդված سائنسی مضمون مقالهٔ علمی bài báo khoa học 1992年学术文章 1992年の論文
p:P577
wds:Q54086129-D6E9D57A-754D-4BD1-9DC9-0C95C5C335C0
wdt:P577
1992-01-01T00:00:00Z
p:P2093
wds:Q54086129-5ADCCFD0-C10B-4C3C-8ADD-329F0C03996D wds:Q54086129-46B7D8FE-9F3B-41E5-A84E-ACCB55CC7A5C wds:Q54086129-87566A97-0E49-44DE-A92D-DAF0230539FE wds:Q54086129-885CBFF0-E15D-4ADF-8AA9-CA1FDAB457D0 wds:Q54086129-935AA65B-2EB3-4DAA-BF4D-507DE9943497 wds:Q54086129-99E07674-1F25-4A69-89C2-75698BA321D9 wds:Q54086129-8D13AF8C-222D-4576-AAE7-35F2674470C0 wds:Q54086129-AFF43B01-5D37-4739-AA46-317C5C903EE9 wds:Q54086129-F06C6C25-FE60-41F4-80D6-B31F9D2F5C19
wdt:P2093
Allen L LoBuglio AF Gillies SD Grizzle W Saleh MN Khazaeli MB Tilden AB Wheeler RH Reisfeld RA
rdfs:label
Phase I trial of the chimeric anti-GD2 monoclonal antibody ch14.18 in patients with malignant melanoma. Phase I trial of the chimeric anti-GD2 monoclonal antibody ch14.18 in patients with malignant melanoma.
skos:prefLabel
Phase I trial of the chimeric anti-GD2 monoclonal antibody ch14.18 in patients with malignant melanoma. Phase I trial of the chimeric anti-GD2 monoclonal antibody ch14.18 in patients with malignant melanoma.
schema:name
Phase I trial of the chimeric anti-GD2 monoclonal antibody ch14.18 in patients with malignant melanoma. Phase I trial of the chimeric anti-GD2 monoclonal antibody ch14.18 in patients with malignant melanoma.
p:P50
wds:Q54086129-119DA1F2-3734-42A6-8D53-AD5FA037A18A
wdt:P50
wd:Q56989429
p:P1476
wds:Q54086129-D48D5D2E-2447-469D-B1B5-A46EFD1A2408
wdt:P1476
Phase I trial of the chimeric anti-GD2 monoclonal antibody ch14.18 in patients with malignant melanoma
p:P304
wds:Q54086129-8063DF4E-FACA-434E-BA8B-56890F64609B
wdt:P304
19-24
p:P31
wds:Q54086129-FFFD4EFB-2C60-43FC-949C-59C0BFA7323B
wdt:P31
wd:Q13442814
p:P921
wds:Q54086129-B34B9764-2C6F-4A5A-801A-F61F475EFC88 wds:Q54086129-8F36A060-4A5D-4AFE-A408-B034C9A580FE wds:Q54086129-471E6BD0-419C-41B2-AC07-B10EB518C843
wdt:P921
wd:Q5452194 wd:Q181600 wd:Q79460
p:P698
wds:Q54086129-C0C8942D-800A-486F-BA1F-E9664D6A7EAC
wdtn:P698
n7:1576319
wdt:P698
1576319
p:P1433
wds:Q54086129-61701909-6D8C-49AE-8ED1-A8E5650F9D91
wdt:P1433
wd:Q27709377
p:P433
wds:Q54086129-E2CA38CB-2B5F-4DD9-BE31-DD8862C455C9
p:P478
wds:Q54086129-B482CB4D-9D75-4D3B-8D41-7B4D3FBE8CDB
wdt:P433
1
wdt:P478
3